Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency (Q91872888)
Jump to navigation
Jump to search
scientific article published on 13 April 2020
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency |
scientific article published on 13 April 2020 |
Statements
Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency (English)
Calvin J Gordon
Joy Y Feng